Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Promin low protein dessert 36.5g sachets chocolate & banana
0913261E0BBAGAD
|
Promin specialist food replacer desserts | Specialist food replacer desserts (0913261) | Nutrition and Blood | 119 |
|
Promin low protein dessert 36.5g sach strawberry & vanilla
0913261E0BBAEAD
|
Promin specialist food replacer desserts | Specialist food replacer desserts (0913261) | Nutrition and Blood | 103 |
|
Promin low protein dessert 36.5g sachets custard
0913261E0BBAHAD
|
Promin specialist food replacer desserts | Specialist food replacer desserts (0913261) | Nutrition and Blood | 82 |
|
Promin low protein dessert 36.5g sachets caramel
0913261E0BBAFAD
|
Promin specialist food replacer desserts | Specialist food replacer desserts (0913261) | Nutrition and Blood | 72 |
|
Promin low protein imitation rice pudding 69g sach original
0913261E0BBABAE
|
Promin specialist food replacer desserts | Specialist food replacer desserts (0913261) | Nutrition and Blood | 53 |
|
Promin low protein imitation rice pudding 69g sach s/berry
0913261E0BBAAAE
|
Promin specialist food replacer desserts | Specialist food replacer desserts (0913261) | Nutrition and Blood | 53 |
|
Promin low protein imitation rice pudding 69g sachets banana
0913261E0BBADAE
|
Promin specialist food replacer desserts | Specialist food replacer desserts (0913261) | Nutrition and Blood | 48 |
|
Promin low protein imitation rice pudding 69g sachets apple
0913261E0BBACAE
|
Promin specialist food replacer desserts | Specialist food replacer desserts (0913261) | Nutrition and Blood | 39 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.